The genetic basis of major depressive disorder
- PMID: 36702864
- PMCID: PMC10611584
- DOI: 10.1038/s41380-023-01957-9
The genetic basis of major depressive disorder
Abstract
The genetic dissection of major depressive disorder (MDD) ranks as one of the success stories of psychiatric genetics, with genome-wide association studies (GWAS) identifying 178 genetic risk loci and proposing more than 200 candidate genes. However, the GWAS results derive from the analysis of cohorts in which most cases are diagnosed by minimal phenotyping, a method that has low specificity. I review data indicating that there is a large genetic component unique to MDD that remains inaccessible to minimal phenotyping strategies and that the majority of genetic risk loci identified with minimal phenotyping approaches are unlikely to be MDD risk loci. I show that inventive uses of biobank data, novel imputation methods, combined with more interviewer diagnosed cases, can identify loci that contribute to the episodic severe shifts of mood, and neurovegetative and cognitive changes that are central to MDD. Furthermore, new theories about the nature and causes of MDD, drawing upon advances in neuroscience and psychology, can provide handles on how best to interpret and exploit genetic mapping results.
© 2023. The Author(s).
Conflict of interest statement
The author declares no competing interests.
Figures


Similar articles
-
Minimal phenotyping yields genome-wide association signals of low specificity for major depression.Nat Genet. 2020 Apr;52(4):437-447. doi: 10.1038/s41588-020-0594-5. Epub 2020 Mar 30. Nat Genet. 2020. PMID: 32231276 Free PMC article.
-
The Australian Genetics of Depression Study: New Risk Loci and Dissecting Heterogeneity Between Subtypes.Biol Psychiatry. 2022 Aug 1;92(3):227-235. doi: 10.1016/j.biopsych.2021.10.021. Epub 2021 Nov 2. Biol Psychiatry. 2022. PMID: 34924174
-
Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy.Mol Psychiatry. 2021 Jun;26(6):2429-2439. doi: 10.1038/s41380-020-00984-0. Epub 2021 Jan 22. Mol Psychiatry. 2021. PMID: 33483693 Free PMC article.
-
The genetics of severe depression.Mol Psychiatry. 2025 Mar;30(3):1117-1126. doi: 10.1038/s41380-024-02731-1. Epub 2024 Oct 15. Mol Psychiatry. 2025. PMID: 39406997 Review.
-
Unraveling the genetic architecture of major depressive disorder: merits and pitfalls of the approaches used in genome-wide association studies.Psychol Med. 2019 Dec;49(16):2646-2656. doi: 10.1017/S0033291719002502. Epub 2019 Sep 27. Psychol Med. 2019. PMID: 31559935 Free PMC article. Review.
Cited by
-
Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.Am J Psychiatry. 2023 Oct 1;180(10):714-722. doi: 10.1176/appi.ajp.20220906. Epub 2023 Aug 30. Am J Psychiatry. 2023. PMID: 37644812 Free PMC article.
-
Clinical and genetic contributions to medical comorbidity in bipolar disorder: a study using electronic health records-linked biobank data.Mol Psychiatry. 2024 Sep;29(9):2701-2713. doi: 10.1038/s41380-024-02530-8. Epub 2024 Mar 28. Mol Psychiatry. 2024. PMID: 38548982 Free PMC article.
-
Human mood disorder risk gene Synaptotagmin-14 contributes to mania-like behaviors in mice.Mol Psychiatry. 2025 Aug;30(8):3466-3477. doi: 10.1038/s41380-025-02933-1. Epub 2025 Feb 18. Mol Psychiatry. 2025. PMID: 39966626
-
Machine learning algorithm-based estimation model for the severity of depression assessed using Montgomery-Asberg depression rating scale.Neuropsychopharmacol Rep. 2024 Mar;44(1):115-120. doi: 10.1002/npr2.12404. Epub 2023 Dec 20. Neuropsychopharmacol Rep. 2024. PMID: 38115795 Free PMC article.
-
The Melanocortin System: A Promising Target for the Development of New Antidepressant Drugs.Int J Mol Sci. 2023 Apr 3;24(7):6664. doi: 10.3390/ijms24076664. Int J Mol Sci. 2023. PMID: 37047638 Free PMC article. Review.